Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation

Research output: Contribution to journalReview articlepeer-review

16 Scopus citations

Fingerprint

Dive into the research topics of 'Anti-interleukin-2 receptor antibodies-basiliximab and daclizumab-for the prevention of acute rejection in renal transplantation'. Together they form a unique fingerprint.

Medicine & Life Sciences